Synthesis of optically pure (S)-2-amino-5-arylpent-4-ynoic acids by Sonogashira reactions and their potential use as highly selective potent inhibitors of aldose reductase

被引:14
|
作者
Parpart, Silvio [1 ]
Petrosyan, Andranik [1 ,2 ,3 ]
Shah, Syed Jawad Ali [5 ]
Adewale, Raji Akeem [5 ]
Ehlers, Peter [1 ]
Grigoryan, Tatevik [1 ,4 ]
Mkrtchyan, Anna F. [3 ,4 ]
Mardiyan, Zorayr Z. [3 ]
Karapetyan, Ani J. [3 ]
Tsaturyan, Avetis H. [3 ]
Saghyan, Ashot S. [3 ,4 ]
Iqbal, Jamshed [5 ]
Langer, Peter [1 ,2 ]
机构
[1] Univ Rostock, Inst Chem, D-18059 Rostock, Germany
[2] Univ Rostock, Leibniz Inst Katalyse eV, D-18059 Rostock, Germany
[3] SPC Armbiotechnol SNPO NAS RA, Yerevan 0056, Armenia
[4] Yerevan State Univ, Fac Pharmacol & Chem, Yerevan 0025, Armenia
[5] COMSATS Inst Informat Technol, Ctr Adv Drug Res, Abbottabad 22060, Pakistan
关键词
ALPHA-AMINO-ACIDS; ALDEHYDE REDUCTASE; NICKEL(II) COMPLEXES; NI(II) COMPLEXES; CHIRAL NI(II)-COMPLEX; ASYMMETRIC-SYNTHESIS; ADDITION-REACTIONS; TERNARY COMPLEX; RATIONAL DESIGN; POLYOL PATHWAY;
D O I
10.1039/c5ra22407a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new and convenient synthesis of optically pure (S)-2-amino-5-[aryl]pent-4-ynoic acids (alkynylated amino acids) is reported. (S)-2-Aminopent-4-ynoic acid-Ni-(S)-BPB was prepared and then functionalized via Sonogashira cross-coupling reactions to give (S)-2-amino-5-[aryl] pent-4-ynoic acidNi-( S)-BPB. The reaction conditions for the cross-coupling reaction were optimized and twelve derivatives were synthesized. Afterwards the Ni-complexes were cleaved to obtain the free (S)-2-amino5-[ aryl] pent-4-ynoic acids with excellent optical purity. The prepared (S)-2-amino-5-[aryl] pent-4-ynoic acids were tested for biological activity and selectively showed high inhibitory activity against aldose reductase (ALR2) over ALR1. Molecular docking studies have also been carried out to identify the putative binding mode of the compounds in these enzymes.
引用
收藏
页码:107400 / 107412
页数:13
相关论文
共 45 条
  • [1] Synthesis of Optically Pure (S,E)-2-Amino-5-arylpent-4-enoic Acids by Heck Reactions of Nickel Complexes
    Parpart, Silvio
    Mardiyan, Zorayr Z.
    Ehlers, Peter
    Petrosyan, Andranik
    Mkrtchyan, Anna F.
    Saghyan, Ashot S.
    Langer, Peter
    SYNLETT, 2018, 29 (06) : 793 - 798
  • [2] (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors
    Kucerova-Chlupacova, Marta
    Halakova, Dominika
    Majekova, Magdalena
    Treml, Jakub
    Stefek, Milan
    Prnova, Marta Soltesova
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 332
  • [3] A Stereoselective Entry to Enantiopure (S)-2-Amino-2-methyl-5-arylpent-4-ynoic Acids and Evaluation of Their Inhibitory Activity against Bacterial Collagenase G
    Hakobyan, Hegine I.
    Jamgaryan, Silva M.
    Sargsyan, Armen S.
    Danghyan, Yuri M.
    Larionov, Vladimir A.
    Maleev, Victor I.
    Saghyan, Ashot S.
    Mardiyan, Zorayr Z.
    SYMMETRY-BASEL, 2023, 15 (10):
  • [4] Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications
    Van Zandt, MC
    Sibley, EO
    McCann, EE
    Combs, KJ
    Flam, B
    Sawicki, DR
    Sabetta, A
    Carrington, A
    Sredy, J
    Howard, E
    Mitschler, A
    Podjarny, AD
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (21) : 5661 - 5675
  • [5] Highly selective aldose reductase inhibitors .1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids
    Ishii, A
    Kotani, T
    Nagaki, Y
    Shibayama, Y
    Toyomaki, Y
    Okukado, N
    Ienaga, K
    Okamoto, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) : 1924 - 1927
  • [6] Highly selective aldose reductase inhibitors .2. Optimization of the aryl part of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids
    Kotani, T
    Ishii, A
    Nagaki, Y
    Toyomaki, Y
    Yago, H
    Suehiro, S
    Okukado, N
    Okamoto, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (02) : 297 - 304
  • [7] Highly selective aldose reductase inhibitors .3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids
    Kotani, T
    Nagaki, Y
    Ishii, A
    Konishi, Y
    Yago, H
    Suehiro, S
    Okukado, N
    Okamoto, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (05) : 684 - 694
  • [8] Synthesis, activity, and molecular modeling of new 2,4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors
    Fresneau, P
    Cussac, M
    Morand, JM
    Szymonski, B
    Tranqui, D
    Leclerc, G
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) : 4706 - 4715
  • [9] Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications
    Van Zandt, Michael C.
    Doan, Brian
    Sawicki, Diane R.
    Sredy, Janet
    Podjarny, Alberto D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) : 2006 - 2008
  • [10] Design, synthesis and molecular modelling of novel methyl[4-oxo-2-(aroylimino)-3-(substituted phenyl)thiazolidin-5-ylidene]acetates as potent and selective aldose reductase inhibitors
    Ali, Sher
    Saeed, Aamer
    Abbas, Naeem
    Shahid, Mohammad
    Bolte, Michael
    Iqbal, Jamshed
    MEDCHEMCOMM, 2012, 3 (11) : 1428 - 1434